Côte d’Ivoire – Contingency plan of the National HIV Programme in the context of the COVID-19 epidemic (Ministry of Health Côte d’Ivoire) (March 2020)
DRC – Note circulaire: Mesures opérationnelles de prise en charge de PvVIHs pendant cette (April 2020)
Eswatini – Memorandum. Guidance on provision of chronic care during the COVID-19 pandemic (Ministry of Health Eswatini) (April 2020)
Eswatini – Community commodity distribution concept note (Ministry of Health Eswatini) (April 2020)
Ethiopia – Interim Guidance for management of people living with HIV in the context of COVID-19 outbreak in Ethiopia (Ministry of Health Ethiopia) (May 2020)
Ghana – Guidance for the Care of Persons Living with HIV (PLHIV) in the Wake of COVID-19 (Ghana Health Service) (March 2020)
India – Guidance Note for Persons engaged in HIV/AIDS response under National AIDS Control Programme in view of the COVID-19 scenario (Ministry of Health and Family Welfare India) (March 2020)
Kenya – COVID-19 guidance on comprehensive HIV service delivery (Ministry of Health Kenya) (March 2020)
Kenya – Updated Operational Guidance on Continuity of Health Services in HIV Prevention, Care and Treatment in the Context of the COVID-19 Pandemic (Kenyan Ministry of Health) (24 August 2020)
Lesotho – Coronavirus Disease – 2019 (COVID-19) Screening, Testing, Clinical Management, and Prevention of COVID-19 Guidelines for Clinicians (July 2020)
Liberia – Interim Guidance for COVID- 19 for all Persons with HIV (Ministry of Health Liberia) (March 2020)
Liberia – National AIDS and STI Control Program SOP for six monthly ART dispensation (Ministry of Health Liberia) (Updated September 2020)
Malawi – COVID-19 guidance for HIV services. Edition 2 (Ministry of Health Malawi) (April 2020)
Malawi – Guidance for HIV Services during COVID-19 pandemic. 4th Edition (Malawian Ministry of Health) (14 August 2020)
Malawi – Guidance for HIV service during COVID-19 Pandemic. 5th Edition (Ministry of Health) (26 January 2021)
Mozambique – Service package for populations living with HIV as part of the COVID-19 response (PORTUGUESE) (Ministry of Health Mozambique) (March 2020)
Sierra Leone – COVID-19 guidance on comprehensive HIV service delivery (National HIV/AIDS Control Programme Sierra Leone) (May 2020)
South Africa – Medicines and Related Substances Act: Exclusion of Schedule 2, Schedule 3, and Schedule 4 Substances from the Operation of Certain Provisions of the Medicines and Related Substances Act (Nov 2020)
South Africa – Exclusion of Schedule 2, Schedule 3, Schedule 4 Substances from the Operation of Certain Provisions of the Medicines and Related Substances Act (May 2020)
South Africa – Response to reduce risk among HIV and TB patients within the context of the COVID-19 pandemic: The South African response to COVID-19 (NDoH South Africa) (April 2020)
South Africa – Guidance to Implementing Partners Regarding Managing Clients on Pre-Exposure Prophylaxis during the State of Emergency COVID-19 (NDoH South Africa) (March 2020)
South Sudan – HIV programme Guidance in the context of COVID-19 Pandemic (South Sudan Ministry of Health) (April 2020)
Tanzania – Second interim guidance on provision of HIV prevention and care services in the context of COVID-19 outbreak in Tanzania (Ministry of Health, Community Development, Gender, Elderly and Children, Tanzania) (2020)
Tanzania – Interim guidance on provision of HIV prevention and care services in the context of COVID-19 outbreak in Tanzania (Ministry of Health, Community Development, Gender, Elderly, and Children, Tanzania) (2020)
Togo – Emergency order for multi-month ART distribution sites (FRENCH) (Ministry of Health and Public Hygiene Togo) (March 2020)
Uganda – COVID-19 infection prevention and control guidance for HIV and TB services delivery (Ministry of Health Uganda) (April 2020)
Uganda – FAQs by health care providers regarding HIV and TB services delivery during COVID-19 lockdown (Ministry of Health) (April 2020)
United Kingdom – British HIV Association COVID-19 interim adult guidance for the management of adults with HIV on antiretroviral treatment (ART) during the coronavirus pandemic (BHIVA) (May 2020)
Zambia – Multi-month dispensation and use of TLE/TLD during the COVID-19 pandemic (Ministry of Health Zambia) (March 2020)
